All lobbying filings

Avenue Solutions

Avenue Solutions filed a Q1 report for Fresenius Medical Care North America on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Fresenius Medical Care North America · Health care company focused on renal and other chronic conditions

As filed: AVENUE SOLUTIONS for FRESENIUS MEDICAL CARE NORTH AMERICA.

All filings by Avenue Solutions · Everything Fresenius Medical Care North America has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Health Issues

Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)

Bills named in this filing 4

H.R. 2199
Restore Protections for Dialysis Patients Act
S. 1173
Restore Protections for Dialysis Patients Act
S. 2730
Kidney Care Access Protection Act
H.R. 6214
Kidney Care Access Protection Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.